Innoviva Inc stock is traded at $19.03, with a volume of 560,889. It is up +0.32% in the last 24 hours and down -8.24% over the past month. Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.
Previous Close:
$18.97
Open:
$19.11
24h Volume:
560,889
Relative Volume:
0.50
Market Cap:
$1.35B
Revenue:
$434.49M
Net Income/Loss:
$504.34M
P/E Ratio:
3.16
EPS:
$6.01
Net Cash Flow:
$181.97M
1W Performance:
-0.37%
1M Performance:
-8.24%
6M Performance:
-17.76%
1Y Performance:
-14.28%
1-Day Range:
$18.95$19.23
1-Week Range:
$18.66$20.10
52-Week Range:
$18.66$25.15
Innoviva Inc Stock (INVA) Company Profile
Name
Innoviva IncSector
HealthcareIndustry
BiotechnologyPhone
(650) 238-9600Address
1350 OLD BAYSHORE HIGHWAY, BURLINGAME, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS